|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-1-7
|
|
pubmed:abstractText |
The transepithelial passage of the orally bioavailable antibacterial agent oxazolidin-2-one (OXa) and 10 derivatives has been studied with human intestinal (Caco-2) and canine renal (MDCK) cell lines grown on polycarbonate filters. The transepithelial passage was assayed in the apical-to-basolateral (AP-to-BL) direction and in the opposite direction (BL to AP) in both cell lines. The observed passage rates of OXa were similar in both directions in the two cell lines, suggesting passive diffusion. This was further confirmed by the fact that transport kinetics were linear as a function of initial concentration. The rates of AP-to-BL passage of OXa and seven of the derivatives in both cell lines were linearly related to lipophilicity, whether expressed as high-passage liquid chromatography retention time or as the logarithm of the n-octanol-water partition coefficient (log P). These data suggest that the lipophilicity of OXa is important for its observed bioavailability after oral administration. Interestingly, three of the derivatives exhibited a higher passage rate than predicted by lipophilicity. Further studies indicated that this transport was saturable, similar in the two directions, and not affected by energy depletion, suggesting the presence of an additional carrier-mediated facilitated-transport mechanism.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-1384349,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-14907713,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-1510430,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-1560365,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-1614980,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-1673839,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-1808606,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-1906749,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-1975619,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-1996641,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-2003608,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-2095572,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-2118955,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-2200685,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-2207118,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-2235888,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-2323519,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-2339093,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-3171973,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-3435127,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-3919034,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-65285,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-7508263,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-7562093,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8008709,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8018702,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8092820,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8112322,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8141777,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8182532,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8224175,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8240230,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8302755,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8333530,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8366068,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8369142,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8371628,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8395502,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8463293,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8466187,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8851588-8507645
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
652-8
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:8851588-Animals,
pubmed-meshheading:8851588-Anti-Infective Agents,
pubmed-meshheading:8851588-Caco-2 Cells,
pubmed-meshheading:8851588-Cell Line,
pubmed-meshheading:8851588-Chromatography, High Pressure Liquid,
pubmed-meshheading:8851588-Dogs,
pubmed-meshheading:8851588-Epithelial Cells,
pubmed-meshheading:8851588-Epithelium,
pubmed-meshheading:8851588-Humans,
pubmed-meshheading:8851588-Intestines,
pubmed-meshheading:8851588-Kidney,
pubmed-meshheading:8851588-Models, Molecular,
pubmed-meshheading:8851588-Oxazoles,
pubmed-meshheading:8851588-Oxazolidinones,
pubmed-meshheading:8851588-Spectrophotometry, Ultraviolet
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Transport of the antibacterial agent oxazolidin-2-one and derivatives across intestinal (Caco-2) and renal (MDCK) epithelial cell lines.
|
|
pubmed:affiliation |
Istituto Nazionale della Nutrizione, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
